We are live on ! Find out more
GLSI icon

Greenwich LifeSciences
GLSI

1 hedge funds and large institutions have $1K invested in Greenwich LifeSciences in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$1.32K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$1K +$1.32K +277 New

GLSI Hedge Fund Activity: Q3 2020 in Review

1 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q3 2020, worth a combined $1K.

Buyers outnumbered sellers: 1 fund opened new GLSI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $1.32K.

  • 1 institutional investor held Greenwich LifeSciences (GLSI) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $1K of Greenwich LifeSciences stock for Q3 2020.
  • 1 fund opened new Greenwich LifeSciences positions in Q3 2020 and 0 closed out, a net change of +1 holder.
  • The largest Greenwich LifeSciences buyer in Q3 2020 was UBS Group, an estimated $1.32K added.

Based on aggregated 13F filings for Q3 2020.